HER2 POSITIVE SOLID TUMOR
Clinical trials for HER2 POSITIVE SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new HER2 POSITIVE SOLID TUMOR trials appear
Sign up with your email to follow new studies for HER2 POSITIVE SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat HER2 cancers: first human trial begins
Disease control Recruiting nowThis early-stage study is testing a new drug called YH32367 in people with advanced HER2-positive solid tumors that have spread. The main goals are to check the drug's safety and find the right dose, while also seeing if it can shrink tumors. About 147 participants will take part…
Matched conditions: HER2 POSITIVE SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New imaging trick could make tumors glow brighter
Diagnosis Recruiting nowThis early-phase study tests a new imaging agent, TGW211, for people with HER2-positive cancers. The goal is to see if a special "trigger" can help clear the imaging tracer from healthy organs, making tumors easier to see on scans. About 19 adults will participate to check safety…
Matched conditions: HER2 POSITIVE SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated May 17, 2026 07:47 UTC